Search results for "Thiouracil"

showing 10 items of 11 documents

Global diversity in the TAS2R38 bitter taste receptor: revisiting a classic evolutionary PROPosal

2016

AbstractThe ability to taste phenylthiocarbamide (PTC) and 6-n-propylthiouracil (PROP) is a polymorphic trait mediated by the TAS2R38 bitter taste receptor gene. It has long been hypothesized that global genetic diversity at this locus evolved under pervasive pressures from balancing natural selection. However, recent high-resolution population genetic studies of TAS2Rs suggest that demographic events have played a critical role in the evolution of these genes. We here utilized the largest TAS2R38 database yet analyzed, consisting of 5,589 individuals from 105 populations, to examine natural selection, haplotype frequencies and linkage disequilibrium to estimate the effects of both selectio…

AFRICASELECTION0301 basic medicineLinkage disequilibriumPopulationLocus (genetics)Taste Genetics Evolutionary geneticsBiologyBalancing selectionLinkage DisequilibriumArticleReceptors G-Protein-CoupledEvolution Molecular03 medical and health sciences0302 clinical medicineDatabases GeneticGenetic variationLOCUSHumansPHENYLTHIOCARBAMIDESelection GeneticeducationPOPULATIONVEGETABLESGeneticsGenetic diversityeducation.field_of_studyHUMAN GENETIC DIVERSITY; SENSITIVITY; POPULATION; AFRICA; PTC; PHENYLTHIOCARBAMIDE; VEGETABLES; SELECTION; HUMANS; LOCUSNatural selectionMultidisciplinaryGenetic Variationphenylthiocarbamide (PTC) and 6-n-propylthiouracil (PROP)- TAS2R38 haplotypes-natural selectionPhenylthioureaCorrigendaSettore BIO/18 - GeneticaPTC030104 developmental biologyTAS2R38HaplotypesPropylthiouracilTasteHUMAN GENETIC DIVERSITYSENSITIVITY030217 neurology & neurosurgery
researchProduct

Orosensory detection of bitter in fat-taster healthy and obese participants: Genetic polymorphism of CD36 and TAS2R38

2017

In Press, Corrected Proof — Note to users; International audience; Background & aimsWe assessed orosensory detection of a long-chain fatty acid, linoleic acid (LA), and a bitter taste marker, 6-n-propylthiouracil (PROP), and correlated lipid-taster subjects with PROP detection and polymorphism in genes encoding bitter and lipid taste receptors, respectively, TAS2R38 and CD36, in normal weight and obese subjects.DesignThe normal weight (n = 52, age = 35.3 ± 4.10 years, BMI = 23.22 ± 1.44 kg/m2) and obese (n = 52, age = 35.0 ± 5.43 years, BMI = 34.29 ± 5.31 kg/m2) participants were recruited to determine fat and bitter detection thresholds. The genomic DNA was used to determine single nucleot…

AdultCD36 AntigensMale0301 basic medicinemedicine.medical_specialtyTaste[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionSingle-nucleotide polymorphismCritical Care and Intensive Care MedicinePolymorphism Single NucleotideReceptors G-Protein-Coupled03 medical and health sciencesstomatognathic systemPolymorphism (computer science)Taste receptorInternal medicineHumansSNPMedicineObesityGenetic polymorphism030109 nutrition & dieteticsNutrition and Dieteticsbusiness.industryBody WeightBitter tastemedicine.diseaseObesityTAS2R38EndocrinologyPropylthiouracilCase-Control StudiesTastebusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionFat tasteBody mass indexClinical Nutrition
researchProduct

2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.

2018

Graves' disease (GD) is a systemic autoimmune disorder characterized by the infiltration of thyroid antigen-specific T cells into thyroid-stimulating hormone receptor (TSH-R)-expressing tissues. Stimulatory autoantibodies (Ab) in GD activate the TSH-R leading to thyroid hyperplasia and unregulated thyroid hormone production and secretion. Diagnosis of GD is straightforward in a patient with biochemically confirmed thyrotoxicosis, positive TSH-R-Ab, a hypervascular and hypoechoic thyroid gland (ultrasound), and associated orbitopathy. In GD, measurement of TSH-R-Ab is recommended for an accurate diagnosis/differential diagnosis, prior to stopping antithyroid drug (ATD) treatment and during p…

Antithyroid drugs; Graves' hyperthyroidism; Graves' orbitopathy; Management; Radioiodine therapy; Thyroidectomy;medicine.medical_specialtyendocrine systemendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolismGuidelinesGastroenterologyGraves' orbitopathy03 medical and health sciences0302 clinical medicineRadioiodine therapyInternal medicinemedicinePregnancyGraves' hyperthyroidismAntithyroid drugsbusiness.industryThyroidThyroidectomyAutoantibodymedicine.diseaseManagementmedicine.anatomical_structureHormone receptor030220 oncology & carcinogenesisThyroidectomyPropylthiouracilDifferential diagnosisbusinessHormonemedicine.drugEuropean thyroid journal
researchProduct

Dificultad en el tratamiento del hipertiroidismo por amiodarona: Presentación de un caso

2007

La amiodarona puede alterar la función tiroidea en un 15-20% de los pacientes que la toman, dando lugar a hipotiroidismo o hipertiroidismo. La sobrecarga de yodo y la toxicidad directa sobre el tiroides inducida por amiodarona pueden provocar hipertiroidismo. Describimos un caso de tirotoxicosis grave por amiodarona que se diagnosticó buscando la causa que descompensó la cardiopatía de base del paciente, condicionando ésta el pronóstico y el manejo terapéutico. El tratamiento precisó un estrecho seguimiento y se basó en dosis elevadas de propiltiouracilo y dexametasona que no controlaron las consecuencias del hipertiroidismo a nivel cardiaco necesitando la tiroidectomia total. Creemos, con …

Cardiac function curveendocrine systemmedicine.medical_specialtyendocrine system diseasesmedicine.diagnostic_testbusiness.industryHipertiroidismo por amiodaronaCorticoterapiaAmiodaronemedicine.diseaseGastroenterologyThyroid function testsThyroiditisSurgeryAntitiroideos de síntesisRefractoryInternal medicineTiroidectomia totalInternal MedicinemedicinePropylthiouracilThyroid functionbusinessDexamethasonemedicine.drugAnales de Medicina Interna
researchProduct

Determination of thyreostatics in animal feed by micellar electrokinetic chromatography

1999

The determination of the thyreostatics 2-thiouracil, its derivatives (4-methyl-2-thiouracil, 4-propyl-2-thiouracil and 4-phenyl-2-thiouracil) and methimazole in manufactured dried animal feed by micellar electrokinetic chromatography (MEKC) is described. A 99 +/- 5% extraction yield at the 20 micrograms g-1 level (n = 8) was achieved by shaking the milled fodder with methanol-1 M NaOH (80 + 20). Aliquots of the supernatant were injected in a 75 microns x 33.5 cm uncoated silica capillary using pressure; separation was performed at 23 degrees C with 15 kV (positive polarity) in a background electrolyte (BGE) containing 40 mM sodium dihydrogenphosphate, 50 mM sodium dodecyl sulfate and 15 mM …

Detection limitChromatographyAnimal feedSodiumExtraction (chemistry)chemistry.chemical_elementAnimal FeedBiochemistryThiouracilMicellar electrokinetic chromatographyAnalytical Chemistrychemistry.chemical_compoundAntithyroid AgentschemistryFodderElectrochemistryAnimalsEnvironmental ChemistrySodium dodecyl sulfateQuantitative analysis (chemistry)SpectroscopyChromatography Micellar Electrokinetic CapillaryThe Analyst
researchProduct

Management of Graves‘Thyroidal And Extrathyroidal Disease – An Update

2020

Abstract Context Invited update on the management of systemic autoimmune Graves disease (GD) and associated Graves orbitopathy (GO). Evidence acquisition Guidelines, pertinent original articles, systemic reviews, and meta-analyses. Evidence synthesis Thyrotropin receptor antibodies (TSH-R-Abs), foremost the stimulatory TSH-R-Abs, are a specific biomarker for GD. Their measurement assists in the differential diagnosis of hyperthyroidism and offers accurate and rapid diagnosis of GD. Thyroid ultrasound is a sensitive imaging tool for GD. Worldwide, thionamides are the favored treatment (12-18 months) of newly diagnosed GD, with methimazole (MMI) as the preferred drug. Patients with persistent…

MalePediatricsendocrine system diseasesdiagnosisEndocrinology Diabetes and Metabolismmedicine.medical_treatmentGraves' diseaseClinical Biochemistryradioactive iodineThyroid GlandBiochemistryHyperthyroidismIodine Radioisotopes0302 clinical medicineEndocrinologyPregnancyUltrasonographytreatmentDisease ManagementReceptors ThyrotropinMini-ReviewGraves Disease030220 oncology & carcinogenesisthyroidectomyBiomarker (medicine)antithyroid drugsFemaleAcademicSubjects/MED00250managementmedicine.drugImmunoglobulins Thyroid-Stimulatingmedicine.medical_specialtyendocrine system030209 endocrinology & metabolismContext (language use)TSH receptor antibodiesDiagnosis Differential03 medical and health sciencesAntithyroid AgentsInternal medicinemedicineHumansRisk factorPregnancyMethimazolebusiness.industryBiochemistry (medical)Thyroidectomymedicine.diseaseGraves OphthalmopathyPregnancy ComplicationsEndocrinologyPropylthiouracilDifferential diagnosisbusinessGraves’ diseaseBiomarkersThe Journal of Clinical Endocrinology and Metabolism
researchProduct

Der Einflu� von BAL und Methionin auf die Schilddr�senhyperplasie nach chronischer Gabe von Methylthiouracil

1954

Bei 45 tagiger Verabreichung wurde an Ratten der Einflus von BAL (30 mg/kg) und Methionin (3 g/kg) auf die durch Methylthiouracil (MTU, 25 mg/kg) verursachten Stoffwechsel-, Schilddrusengewichts-und-aktivitatsanderungen untersucht. Die Ergebnisse sind statistisch gesichert.

Pharmacologymedicine.medical_specialtyMethioninebusiness.industryPharmacology toxicologyCystineGeneral MedicineMethylthiouracilchemistry.chemical_compoundEndocrinologychemistryInternal medicineMedicineThyroid hyperplasiabusinessmedicine.drugNaunyn-Schmiedebergs Archiv f�r Experimentelle Pathologie und Pharmakologie
researchProduct

Organomercury(II) derivatives of 2-thiouracil. An infrared and proton magnetic resonance study of structures

1983

Abstract The novel complexes RHg(s2UraH−1) (R = Me, Ph) where s2UraH−1 is the monoanion of 2-thiouracil, have been synthesized. Comparison of the infrared spectra of the solid complexes and of 1H nuclear magnetic resonance spectra of the complexes in dimethyl-d6 sulfoxide with spectra of s2 Ura and Na[s2UraH−1] allows the recognition of the existence of isomers in the solid, with bonding to exocyclic sulfur and to pyrimidine nitrogens. In solution, a simpler pattern is observed, with 2J(1H199Hg) indicating bonding to sulfur only.

PyrimidineInfraredAnalytical chemistryInfrared spectroscopychemistry.chemical_elementSulfoxideSulfurSpectral lineThiouracilInorganic Chemistrychemistry.chemical_compoundCrystallographychemistryMaterials ChemistryOrganomercuryPhysical and Theoretical ChemistryInorganica Chimica Acta
researchProduct

A 2013 European survey of clinical practice patterns in the management of Graves' disease

2014

SummaryObjective Management of Graves' disease (GD) in Europe was published in 1987. Aim of this survey was to provide an update on clinical practice in Europe, and to compare it with a 2011 American survey. Design Members of the European Thyroid Association (ETA) were asked to participate in a survey on management of GD, using the same questionnaire of a recent American survey. Results A total of 147 ETA members participated. In addition to serum TSH and free T4 assays, most respondents would request TSH-receptor autoantibody (TRAb) measurement (85·6%) and thyroid ultrasound (70·6%) to confirm aetiology, while isotopic studies were selected by 37·7%. Antithyroid drug (ATD) therapy was the …

medicine.medical_specialtyExacerbationEndocrinology Diabetes and MetabolismGraves' diseaseThyrotropin030209 endocrinology & metabolismTrabDisease03 medical and health sciences0302 clinical medicineEndocrinologyAntithyroid AgentsPregnancySurveys and QuestionnairesInternal medicinemedicineHumansPractice Patterns Physicians'AutoantibodiesPregnancyMethimazolebusiness.industryThyroidReceptors Thyrotropinmedicine.diseaseGraves DiseaseEuropePregnancy ComplicationsThyroxineEndocrinologymedicine.anatomical_structurePropylthiouracil030220 oncology & carcinogenesisNorth AmericaEtiologyFemalePropylthiouracilbusinessmedicine.drugClinical Endocrinology
researchProduct

Thyroid hormones induce sumoylation of the cold shock domain-containing protein PIPPin in developing rat brain and in cultured neurons.

2006

We previously identified a cold shock domain (CSD)-containing protein (PIPPin), expressed at high level in brain cells. PIPPin has the potential to undergo different post-translational modifications and might be a good candidate to regulate the synthesis of specific proteins in response to extracellular stimuli. Here we report the effects of thyroid hormone (T3) on PIPPin expression in developing rat brain. We found that a significant difference among euthyroid- and hypothyroid- newborn rats concerns sumoylation of nuclear PIPPin, that is abolished by hypothyroidism. Moreover, T3-dependence of PIPPin sumoylation has been confirmed in cortical neurons purified from brain cortices and culture…

medicine.medical_specialtySUMO-1 ProteinSUMO proteinDeveloping rat brainNerve Tissue ProteinsEndocrinologyAntithyroid AgentsHypothyroidismPregnancyInternal medicinemedicineExtracellularAnimalsRats WistarCells CulturedCell NucleusCerebral CortexNeuronsbiologyRNA-Binding ProteinsCold-shock domainChromatinProtein Structure TertiaryRatsThyroid hormoneChemically defined mediumCell nucleusmedicine.anatomical_structureHistoneEndocrinologyAnimals NewbornPropylthiouracilPrenatal Exposure Delayed Effectsbiology.proteinTriiodothyronineRNA-binding proteins (RBPs)FemaleRabbitsNucleusEndocrinology
researchProduct